These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26010941)

  • 1. Squamous Cell Neoplasm of the Ocular Surface in a Patient With Psoriasis Treated With Tumor Necrosis Factor-Alpha Inhibitors.
    Lezcano Carduz VP; Mingo Botín D; Durán Poveda SP
    Cornea; 2015 Jul; 34(7):833-4. PubMed ID: 26010941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
    Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
    Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
    Esquenazi S; Fry CL; Holley E
    Br J Ophthalmol; 2005 Sep; 89(9):1221. PubMed ID: 16113387
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL; Ramasubramanian A; Mellen PL; Shields JA
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alpha-2a as alternative treatment for conjunctival squamous cell carcinoma.
    Cruzado-Sánchez D; Salas-Diaz M; Tellez WA; Alvarez-Matos SE; Serpa-Frías S
    Arch Soc Esp Oftalmol; 2017 Nov; 92(11):539-542. PubMed ID: 28522115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
    [No Abstract]   [Full Text] [Related]  

  • 13. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular surface squamous neoplasia treated with topical interferon α 2b.
    Pujari A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
    Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
    J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors.
    Muñoz de Escalona Rojas JE; García Serrano JL; Cantero Hinojosa J; Padilla Torres JF; Bellido Muñoz RM
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):489-94. PubMed ID: 24749813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.